Literature DB >> 16533478

Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation.

G Kenneth Johnson1, Kia Saeian, Joseph E Geenen.   

Abstract

Primary sclerosing cholangitis (PSC) is an important cause of chronic liver disease. We review the management of PSC and report a 20-year follow-up of our initial 10 patients. This is the longest detailed follow-up of a group of PSC patients to date. We discuss the clinical course and results of endoscopic management in these patients and relate these data to management of PSC in general. We compare the actual survival of these patients to predicted survival scores based on the Mayo multicenter survival model. Although our patients presented with cholangitis, which typically reflects advanced stages of liver disease, their survival compares favorably with expected survival in unselected PSC patients. Endoscopic balloon dilation of PSC patients presenting with biliary strictures and cholangitis may have long-term benefit in addition to short-term symptomatic relief.

Entities:  

Mesh:

Year:  2006        PMID: 16533478     DOI: 10.1007/s11894-006-0011-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  45 in total

1.  Primary sclerosing cholangitis: a premalignant condition.

Authors:  Laurence Blendis; Yoav Lurie
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

2.  Primary sclerosing cholangitis in which differential diagnosis from gallbladder carcinoma was difficult.

Authors:  Hiroyuki Kobayashi; Ryo Hosotani; Yukihiro Imai; Kaori Wada; Tatehiro Kajiwara
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

3.  Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.

Authors:  M Kaya; B T Petersen; P Angulo; T H Baron; J C Andrews; C J Gostout; K D Lindor
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

4.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Authors:  Annika Bergquist; Anders Ekbom; Rolf Olsson; Dan Kornfeldt; Lars Lööf; Ake Danielsson; Rolf Hultcrantz; Stefan Lindgren; Hanne Prytz; Hanna Sandberg-Gertzén; Sven Almer; Fredrik Granath; Ulrika Broomé
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

5.  Sclerosing cholangitis.

Authors:  George R MacFaul; Roger W Chapman
Journal:  Curr Opin Gastroenterol       Date:  2004-05       Impact factor: 3.287

6.  Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.

Authors:  Adolf Stiehl; Gerda Rudolph; Petra Klöters-Plachky; Peter Sauer; Siegfried Walker
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

7.  Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  J K Ramage; A Donaghy; J M Farrant; R Iorns; R Williams
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

8.  Risk factors in primary sclerosing cholangitis.

Authors:  E Schrumpf; M Abdelnoor; O Fausa; K Elgjo; E Jenssen; F Kolmannskog
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

Review 9.  Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation.

Authors:  S J Knechtle; A M D'Alessandro; B A Harms; J D Pirsch; F O Belzer; M Kalayoglu
Journal:  Surgery       Date:  1995-10       Impact factor: 3.982

Review 10.  Endoscopic management of primary sclerosing cholangitis: review, and report of an open series.

Authors:  A A Gaing; J M Geders; S A Cohen; J H Siegel
Journal:  Am J Gastroenterol       Date:  1993-12       Impact factor: 10.864

View more
  9 in total

1.  ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; M Edwyn Harrison
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

2.  Primary sclerosing cholangitis: A review and update.

Authors:  James H Tabibian; Christopher L Bowlus
Journal:  Liver Res       Date:  2017-12

3.  A comparison of balloon- versus stent-based approach for dominant strictures in primary sclerosing cholangitis: a meta-analysis.

Authors:  Amaninder S Dhaliwal; Yassin Naga; Daryl Ramai; Syed M Saghir; Sarav G Daid; Banreet Dhindsa; Andrew Ofosu; Pushpak Taunk
Journal:  Ann Gastroenterol       Date:  2022-03-25

Review 4.  Endoscopic and surgical management of primary sclerosing cholangitis.

Authors:  Anthony Michaels; Cynthia Levy
Journal:  Medscape J Med       Date:  2008-10-21

Review 5.  Primary sclerosing cholangitis--what is the difference between east and west?

Authors:  Ali Shorbagi; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 6.  Endoscopy in the management of primary sclerosing cholangitis.

Authors:  Mark McLoughlin; Robert Enns
Journal:  Curr Gastroenterol Rep       Date:  2008-04

Review 7.  The neglected biliary mucus and its phosphatidylcholine content: a putative player in pathogenesis of primary cholangitis-a narrative review article.

Authors:  Wolfgang Stremmel; Martina Lukasova; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2021-04

8.  Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist.

Authors:  Adnan Malik; Ani A Kardashian; Kais Zakharia; Christopher L Bowlus; James H Tabibian
Journal:  Liver Res       Date:  2019-05-27

9.  Clinical guidelines for primary sclerosing cholangitis 2017.

Authors:  Hiroyuki Isayama; Susumu Tazuma; Norihiro Kokudo; Atsushi Tanaka; Toshio Tsuyuguchi; Takahiro Nakazawa; Kenji Notohara; Suguru Mizuno; Nobuhisa Akamatsu; Masahiro Serikawa; Itaru Naitoh; Yoshiki Hirooka; Toshifumi Wakai; Takao Itoi; Tomoki Ebata; Shinji Okaniwa; Terumi Kamisawa; Hiroki Kawashima; Atsushi Kanno; Keiichi Kubota; Masami Tabata; Michiaki Unno; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2018-06-27       Impact factor: 7.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.